Who Should Get a Covid-19 Vaccine First?

In the United States, the standard approach to distributing a routine vaccine is based on the assumption that there will be plenty of doses available. Ideally, everyone will then follow their doctors’ recommendations when it comes to being immunized against the germ in question. As a practical matter, though, rarely are both of those conditions…

Smokers switching exclusively to glo significantly reduce exposure to certain toxicants

New research by BAT has found that smokers who switched completely from smoking cigarettes to using BAT’s flagship tobacco heating product (THP), glo, substantially reduced their exposure to certain cigarette smoke toxicants over three months. For many of the toxicants measured, the levels found in participants were similar to those in people that stopped using…

SARS-CoV-2 uses ‘genome origami’ to infect and replicate inside host cells

Scientists at the University of Cambridge, in collaboration with Justus-Liebig University, Germany, have uncovered how the genome of SARS-CoV-2 – the coronavirus that causes COVID-19 – uses genome origami to infect and replicate successfully inside host cells. This could inform the development of effective drugs that target specific parts of the virus genome, in the…

De novo protein decoys block COVID-19 infection in vitro and protect animals in vivo

Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2. This report details the creation of de novo protein decoys that were specifically…